, Tracking Stock Market Picks
Enter Symbol:
Ariad Pharmaceuticals, Inc. (ARIA) [hlAlert]

up 243.84 %

Ariad Pharmaceuticals, Inc. (ARIA) rated Outperform with price target $7 by Oppenheimer

Posted on: Thursday,  Oct 10, 2013  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) on 10/10/2013. Previously Oppenheimer rated Outperform Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) on 08/17/2009.,
when the stock price was $2.03. Since then, Ariad Pharmaceuticals, Inc. has gained 243.84% as of 01/19/2016's recent price of $6.98.
If you would have followed the previous Oppenheimer's recommendation on ARIA, you would have gained 243.84% of your investment in 2346 days.

Ariad Pharmaceuticals is engaged in the discovery and development of novel pharmaceuticals based on intracellular signaling technology. The Company has established highly integrated capabilities in functional genomics, molecular cell biology, structure based drug design, combinatorial chemistry and pharmacology. The company is developing small-molecule drugs that block signal transduction pathways in cells responsible for osteoporosis, and immune and inflammatory diseases.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/10/2013 8:25 AM Buy
5.68 7.00
as of 12/13/2013
1 Week down  -2.21 %
1 Month up  64.46 %
3 Months down  -80.72 %
1 YTD down  -79.24 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/30/2013 8:25 AM Buy
18.05 24.00
10/23/2012 8:25 AM Buy
22.30 23.00
8/17/2009 8:25 AM Buy
2.03 4.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy